isuzinaxib   Click here for help

GtoPdb Ligand ID: 11985

Synonyms: APX-115 | APX115 | EWHA-18278 (free base)
Compound class: Synthetic organic
Comment: Isuzinaxib (APX-115) is a first-in-class pan-NADPH oxidase (NOX) inhibitor [1]. We show the chemical structure for the free base, but it is generally delivered as the hydrochloride salt. Isuzinaxib was designed to reduce cellular oxidative stress and tissue injury caused by imbalanced reactive oxygen species (ROS) production in pathological condtions. NADPH oxidases (NOX1-5, DUOX1 and DUOX2) are the major sources of ROS. The effects of pan-NOX inhibition by isuzinaxib can be compared with the effects of the dual NOX1/NOX4 inhibitor setanaxib (GKT137831) [2].

COVID-19: ROS production in response to virus infection are known activators that promote apoptosis, lung injury, and inflammation. Isuzinaxib is being evaluated as a clinical agent that may reduce ROS-induced tissue damage in SARS-CoV-2 infected patients.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 1
Hydrogen bond donors 1
Rotatable bonds 4
Topological polar surface area 50.16
Molecular weight 279.14
XLogP 4.35
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCCc1c([nH]n(c1=O)c1ccccn1)c1ccccc1
Isomeric SMILES CCCc1c([nH]n(c1=O)c1ccccn1)c1ccccc1
InChI InChI=1S/C17H17N3O/c1-2-8-14-16(13-9-4-3-5-10-13)19-20(17(14)21)15-11-6-7-12-18-15/h3-7,9-12,19H,2,8H2,1H3
InChI Key GIWZEELPLKPYBA-UHFFFAOYSA-N
Bioactivity Comments
Isuzinaxib (APX-115) protects from renal injury in diabetic rodent models [3-4]. It reduces expression of inflammatory and pro-fibrotic mediators [1].